Recent Advances in Cell-Based Therapies for Ischemic Stroke

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cardiovascular Research

Background:

• Stroke is a leading global cause of death and disability.
• Current treatments for stroke are limited.
• Stem cell therapy is a promising new avenue for neurological disorder treatment.

Purpose of the Study:

• To review recent advancements in stem cell-based therapies for stroke.
• To highlight various stem cell types investigated for stroke treatment.
• To discuss the current status of clinical trials in this field.

Main Methods:

• Literature review of preclinical and clinical studies on stem cell therapy for stroke.
• Analysis of different stem cell types, including bone marrow mononuclear cells, mesenchymal stem cells, dental pulp stem cells, neural stem cells, induced pluripotent stem cells, and genetically modified stem cells.
• Summary of findings from animal models and human clinical trials.

Main Results:

• Multiple stem cell types have demonstrated potential to improve neurological outcomes in stroke animal models.
• Ongoing clinical trials are evaluating the efficacy of these therapies in human stroke patients.
• Significant progress has been made in understanding the mechanisms and applications of stem cell therapy for stroke.

Conclusions:

• Stem cell-based therapy represents a significant advancement in the potential treatment of stroke.
• Further research and clinical trials are crucial to establish the safety and efficacy of these therapies.
• Cell-based treatments offer hope for improving functional recovery and reducing disability after stroke.